Pharmaceutical Industry Today

Aquatic Veterinary Treatment Market Analysis: Steady Growth Ahead Through 2030

The global aquatic veterinary treatment market is expanding steadily, driven by growing aquaculture industries, rising seafood demand, increasing aquatic diseases, and ongoing innovations in fish vaccines and medications.
Published 18 March 2026

According to The Insight Partners – The global aquatic veterinary treatment market is on a steady upward trajectory, fueled by the rapid expansion of the aquaculture industry, rising incidence of infectious diseases among aquatic species, and surging worldwide demand for seafood and other aquatic food products. According to a comprehensive market analysis by The Insight Partners, the aquatic veterinary treatment market size is projected to grow from US$ 1.2 billion in 2022 to US$ 1.6 billion by 2030, recording a CAGR of 3.9% during the forecast period.

What Is Aquatic Veterinary Treatment?

The aquatic veterinary treatment discipline involves complete healthcare for aquatic animals, including fish, mollusks, and other aquatic species. The market is growing due to the development of aquaculture industries worldwide, growing infectious diseases among aquatic animals, and the surging demand for food products derived from them. Ongoing innovation in fish vaccines is also creating significant new opportunities for market participants.

Key Growth Drivers

The primary engine behind this market's growth is the booming global aquaculture industry. Global aquatic food consumption increased from 28 million metric tons in 1961 to 158 million metric tons in 2019, growing at an average annual rate of 3.0% — nearly double the global population growth rate of 1.6% over the same period.

Asia Pacific, Europe, and South Asia are the main aquaculture regions, together accounting for more than 70% of global aquaculture production. Fish dominate aquaculture, accounting for 66% of the market, followed by crustaceans and mollusca.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00038972 

The 1990–2020 period witnessed rapid aquaculture development, with aquaculture contributing 61.7% to total production in upper-middle-income countries by 2020, up from just 19.8% in 1990. This dramatic expansion has correspondingly elevated the need for effective veterinary interventions to protect aquatic animal health and improve yield.

Market Segmentation

The report segments the aquatic veterinary treatment market across several dimensions — treatment type, species, disease source, and route of administration.

By treatment, the market covers vaccines, medications, and supplements. The medications segment held a significant market share in 2022 and is anticipated to register the highest CAGR during the forecast period. 

Based on species, the fish segment held the largest market share in 2022 and is anticipated to register the fastest CAGR through 2030. By disease source, the bacterial segment held a significant share in 2022 and is estimated to register the highest CAGR during the forecast period. In terms of route of administration, the water medication segment held a significant share and is expected to register the highest CAGR through 2030.

Regional Landscape

In 2022, North America captured a significant share of the market, driven by the expanding aquaculture industry, rising demand for aquatic animal-derived food products, and growing development of new aquaculture vaccines. According to the National Oceanic and Atmospheric Administration, aquaculture generates approximately US$ 1.5 billion annually in the US.

Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00038972 

Competitive Landscape and Recent Developments

The market features several prominent players, including Merck & Co. Inc., Zoetis LLC, HIPRA, Phibro Animal Health Corp, Boehringer Ingelheim Animal Health, Elanco Animal Health Inc., and AquaTactics Fish Health, among others.

Key industry moves reflect the market's dynamism. In November 2022, Indian Immunologicals Ltd joined hands with the Central Institute of Fisheries Education for the commercial development of India's first fish vaccine, aimed at protecting freshwater fish against common bacterial diseases. Similarly, in July 2020, Zoetis acquired the Fish Vet Group from Benchmark Holdings as a strategic addition to its Pharmaq business, which advances and commercializes fish vaccines and provides vaccination and diagnostic services for aquaculture.

Outlook

With per capita seafood consumption rising, aquaculture production expanding across developing economies, and innovation in vaccine development accelerating, the aquatic veterinary treatment market is well-positioned for sustained growth through 2030. Stakeholders across the aquaculture and animal health value chain stand to benefit significantly from these evolving dynamics.

Related Reports @

Aquatic Veterinary Market Size, Trends & Forecast to 2031

Mobile Veterinary Care Market Growth, Analysis, and Forecast by 2031

Animal Parasiticides Market Size, Segments, and Growth by Forecast by 2031

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish

Other Industry News

Ready to start publishing

Sign Up today!